Understanding Genetic Testing for Hypertrophic Cardiomyopathy

Explore how genetic testing informs diagnosis, management, and family risk for hypertrophic cardiomyopathy.

By Medha deb

Created on Sep 25, 2025

Explore how genetic testing informs diagnosis, management, and family risk for hypertrophic cardiomyopathy.

Genetic Testing and Hypertrophic Cardiomyopathy: What You Need to Know

Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease, affecting over 1 in 500 people. Genetic testing has become essential in diagnosing HCM, understanding individual risk, and guiding family screening. This comprehensive article explores how genetic testing works for HCM, who should get tested, what results mean, and the implications for families and future generations.

What Is Hypertrophic Cardiomyopathy?

Hypertrophic cardiomyopathy (HCM) is a genetic condition in which the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively. Many people with HCM experience no symptoms, while others may develop chest pain, shortness of breath, palpitations, or an increased risk of sudden cardiac death.

Most inherited heart condition: HCM is the most frequent cardiogenetic disorder worldwide.
Variable presentation: Symptoms and severity often differ, even within the same family.
Silent carriers: Some people with the genetic mutation may never develop symptoms.

Overview: The Genetics of HCM

HCM is most often caused by genetic mutations that affect proteins in the heart muscle, specifically in the cardiac sarcomere (the contractile unit of the heart). Understanding these genetic roots helps guide diagnosis and family management.

Autosomal dominant inheritance: Only one copy of the altered gene (from either parent) is needed to inherit the risk of HCM.
Known gene mutations: Over 26 genes linked to HCM, with MYH7 and MYBPC3 the most frequently involved.
Mutation effect: Mutations disrupt the way the heart muscle contracts and uses energy, compromising its function.
Penetrance: Not everyone who inherits a mutation will develop HCM; the severity and onset can vary widely.

Inheritance Patterns and Family Risk

Inheritance	Risk per Child	Implications
Autosomal dominant	50% chance each child will inherit the mutation	Testing first-degree relatives (parents, siblings, children) is crucial
Variable penetrance	Not all who inherit will develop symptoms	Close monitoring and periodic screening needed

What Is Genetic Testing for HCM?

Genetic testing for HCM involves examining a person’s DNA, typically from a blood or saliva sample, to look for changes (mutations) in genes known to cause the disease.

Test type: Most often, gene panel tests are used to analyze several HCM-related genes simultaneously.
Sample needed: Blood or saliva provides enough DNA for analysis.
Technology: Next generation sequencing (NGS) allows rapid, detailed examination of multiple genes.

Goals of Genetic Testing

Confirm the clinical diagnosis of HCM.
Identify the specific genetic cause in affected individuals.
Enable cascade testing for at-risk family members.
Distinguish true HCM from look-alike conditions (phenocopies).
Inform prognosis, management, and family planning decisions.

Who Should Consider Genetic Testing for HCM?

Genetic testing is generally recommended for:

Individuals with a confirmed or suspected diagnosis of HCM.
First-degree relatives (parents, siblings, children) of someone diagnosed with HCM.
Family members of someone who died suddenly and unexpectedly at a young age.
Families where multiple relatives have developed unexplained heart conditions or sudden cardiac events.

When a genetic cause is identified in one family member, testing can help clarify the risk for others and may guide who should have continued cardiac screening.

Genetic Counseling: Essential Support

Because test results can affect lifelong health decisions, genetic counseling is a vital part of the process. Genetic counselors:

Explain the benefits, limitations, and possible outcomes of testing.
Help patients and families understand inheritance patterns and risks.
Interpret complex genetic information in a clear, actionable way.
Offer support for emotional or psychological responses to genetic information.

The Genetic Testing Process: What to Expect

Referral and initial counseling: The process typically starts with a referral from a cardiologist or genetic counselor.
Consent and education: You’ll discuss what the tests look for, what results might mean, and potential downstream effects for yourself and your relatives.
Sample collection: A blood or saliva sample is collected at a medical facility or sometimes at home with a kit.
Laboratory analysis: The sample is sent to a certified lab, where specialists analyze genes known to be linked to HCM.
Results and follow-up counseling: When results are ready (often in a few weeks), a counselor reviews them with you and discusses next steps for you and your family.

Possible Genetic Test Outcomes

Positive result: A mutation known to cause HCM is found. First-degree relatives should be tested for the same change.
Negative result: No known HCM-causing mutation is identified. Further screening is based on personal and family cardiac history.
Variant of uncertain significance (VUS): A genetic change is found, but its impact is unclear. Pending further scientific information, decisions are based on clinical findings and family history.

Benefits and Limitations of Genetic Testing

Benefits

Clarifies risk: Identifies which family members are at higher risk and need ongoing heart monitoring.
Enables early intervention: At-risk relatives can undergo periodic screening to detect HCM early, when treatment may be most effective.
Relieves anxiety: Family members who test negative for a known familial mutation can be relieved of the burden of regular screening.
Guides family planning: Individuals can make informed choices about having children, knowing potential risks.
Personalizes care: Genetic findings can inform tailored treatment strategies, such as surveillance for arrhythmias or medications suited to specific mutations.

Limitations

Detection rate is not 100%: Current tests identify the cause in about 60% of individuals with clear HCM findings.
Not all carriers develop HCM: Incomplete penetrance means some mutation carriers never show symptoms.
Variants of uncertain significance: These can be challenging to interpret and may not provide clear answers.
Emotional and psychosocial impact: Learning about a genetic risk can trigger complex feelings or family tensions.
Potential insurance or privacy concerns: While laws protect against genetic discrimination in many regions, some concerns persist.

Implications for Families: Cascade Testing and Beyond

Identifying a genetic mutation in one person opens the door for cascade testing in their biological relatives:

First-degree relatives have a 50% risk of inheriting the same mutation.
Relatives who carry the mutation need regular heart checks; those without typically do not.
Unidentified mutations or negative tests in affected individuals mean more emphasis on clinical screening for family members.

Genetic testing can also assist in distinguishing HCM from similar conditions and inform reproductive decisions (e.g., considering preimplantation genetic diagnosis).

Frequently Asked Questions (FAQs) About Genetic Testing for HCM

Q: What are the signs and symptoms of HCM?

A: Common symptoms include chest pain, shortness of breath, palpitations, fainting (especially during exertion), and, rarely, sudden cardiac arrest. Many people are asymptomatic, making family history and screening vital.

Q: Does a negative genetic test mean I am not at risk for HCM?

A: Not necessarily. Current tests explain the genetic cause in about 60% of families, so a negative result doesn’t fully rule out genetic risk if clinical signs suggest HCM. Regular cardiac evaluations remain important if you have a family history.

Q: How often should family members be screened for HCM?

A: First-degree relatives of someone with HCM—especially those who test positive for a familial mutation—should receive periodic cardiac imaging. Children and teens may be screened annually; adults, every 3–5 years, depending on age and symptoms.

Q: Can having an HCM mutation affect health or life insurance?

A: In many regions, laws protect against health insurance discrimination based on genetic information. Life and disability insurance are not always fully included in protections, so genetic counseling about the implications is important before testing.

Q: Are there treatments tailored to specific genetic mutations?

A: Most HCM management focuses on relieving symptoms and preventing complications. Some research suggests certain mutations may carry higher risks or respond differently to therapy, but treatment is still largely guided by clinical findings.

Q: What is next-generation sequencing (NGS) and why is it used?

A: NGS is a technology that enables rapid, comprehensive analysis of numerous genes at once. For HCM, it’s the standard tool to search for known disease-causing mutations in a single test.

Q: What happens if a variant of uncertain significance is found?

A: Doctors and genetic counselors track the scientific literature over time and may eventually reclassify some variants. In the meantime, clinical decisions are based on symptoms, family history, and other risk factors—not just on the uncertain genetic result.

Key Takeaways

Genetic testing is central to diagnosing HCM and guiding family screening.
Results can clarify risk, inform management, and help reduce unnecessary anxiety and testing for relatives.
Genetic counseling is critical to help interpret results and support patients and families in understanding the broader implications.
The field is evolving—ongoing research continues to improve testing sensitivity and our ability to tailor care.

References & Resources

Centers for Disease Control and Prevention (CDC): About Hypertrophic Cardiomyopathy
Columbia Cardiology: Hypertrophic Cardiomyopathy Genetic Testing
Hypertrophic Cardiomyopathy Association: Genetic Testing Overview
University of Utah Health: HCM Genetic Causes & Testing
Peer-reviewed journal articles on the role of genetic testing and genetic counseling in HCM management.

References

Author

medha deb

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb